Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	FZD6 OR5D16 GABRG2 GABRG3 OR10AG1 OR4K2 GPR50 P2RY12 CCR9 OR9Q1 OR1A2 GPRC6A SMIM17 OR4B1 OR8U3 GABBR2 OR8B2 OR10T2 GPR176 GPR139 CHRNB2 OR1L4 OR8G1	6.13e-13	1353	57	23	GO:0004888
GeneOntologyMolecularFunction	G protein-coupled receptor activity	FZD6 OR5D16 OR10AG1 OR4K2 GPR50 P2RY12 CCR9 OR9Q1 OR1A2 GPRC6A OR4B1 OR8U3 GABBR2 OR8B2 OR10T2 GPR176 GPR139 OR1L4 OR8G1	2.02e-12	884	57	19	GO:0004930
GeneOntologyMolecularFunction	olfactory receptor activity	OR5D16 OR10AG1 OR4K2 OR9Q1 OR1A2 SMIM17 OR4B1 OR8U3 OR8B2 OR10T2 OR1L4 OR8G1	2.58e-09	431	57	12	GO:0004984
GeneOntologyMolecularFunction	odorant binding	OR5D16 OR9Q1 OR8U3 OR8B2 OR10T2 OR8G1	1.64e-06	127	57	6	GO:0005549
GeneOntologyMolecularFunction	GABA receptor activity	GABRG2 GABRG3 GABBR2	3.27e-05	22	57	3	GO:0016917
GeneOntologyMolecularFunction	transmembrane transporter activity	GABRG2 SLC38A2 GABRG3 SLC22A9 KCND2 SLC35B4 SLC35E3 ABCC2 CCDC51 SLC29A2 SLC2A1 CHRNB2	1.02e-04	1180	57	12	GO:0022857
GeneOntologyMolecularFunction	transporter activity	GABRG2 SLC38A2 GABRG3 SLC22A9 KCND2 SLC35B4 SLC35E3 ABCC2 CCDC51 SLC29A2 SLC2A1 CHRNB2	2.33e-04	1289	57	12	GO:0005215
GeneOntologyMolecularFunction	benzodiazepine receptor activity	GABRG2 GABRG3	4.33e-04	11	57	2	GO:0008503
GeneOntologyMolecularFunction	transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential	GABRG2 GABRG3 CHRNB2	5.78e-04	57	57	3	GO:1904315
GeneOntologyMolecularFunction	carbohydrate derivative transmembrane transporter activity	SLC35B4 SLC35E3 SLC29A2	6.40e-04	59	57	3	GO:1901505
GeneOntologyMolecularFunction	nucleobase-containing compound transmembrane transporter activity	SLC35B4 SLC35E3 SLC29A2	6.40e-04	59	57	3	GO:0015932
GeneOntologyMolecularFunction	neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential	GABRG2 GABRG3 CHRNB2	6.72e-04	60	57	3	GO:0099529
GeneOntologyMolecularFunction	nucleotide-sugar transmembrane transporter activity	SLC35B4 SLC35E3	7.13e-04	14	57	2	GO:0005338
GeneOntologyMolecularFunction	transmitter-gated channel activity	GABRG2 GABRG3 CHRNB2	8.50e-04	65	57	3	GO:0022835
GeneOntologyMolecularFunction	transmitter-gated monoatomic ion channel activity	GABRG2 GABRG3 CHRNB2	8.50e-04	65	57	3	GO:0022824
GeneOntologyMolecularFunction	GABA-gated chloride ion channel activity	GABRG2 GABRG3	1.19e-03	18	57	2	GO:0022851
GeneOntologyMolecularFunction	postsynaptic neurotransmitter receptor activity	GABRG2 GABRG3 CHRNB2	1.29e-03	75	57	3	GO:0098960
GeneOntologyMolecularFunction	GABA-A receptor activity	GABRG2 GABRG3	1.33e-03	19	57	2	GO:0004890
GeneOntologyMolecularFunction	extracellular ligand-gated monoatomic ion channel activity	GABRG2 GABRG3 CHRNB2	1.39e-03	77	57	3	GO:0005230
GeneOntologyMolecularFunction	organic anion transmembrane transporter activity	SLC38A2 SLC22A9 SLC35B4 ABCC2 SLC2A1	1.48e-03	293	57	5	GO:0008514
GeneOntologyMolecularFunction	fatty acid transmembrane transporter activity	SLC22A9 SLC2A1	1.95e-03	23	57	2	GO:0015245
GeneOntologyMolecularFunction	ligand-gated monoatomic ion channel activity	GABRG2 GABRG3 CCDC51 CHRNB2	2.24e-03	193	57	4	GO:0015276
GeneOntologyMolecularFunction	ligand-gated channel activity	GABRG2 GABRG3 CCDC51 CHRNB2	2.41e-03	197	57	4	GO:0022834
GeneOntologyMolecularFunction	gated channel activity	GABRG2 GABRG3 KCND2 CCDC51 CHRNB2	2.61e-03	334	57	5	GO:0022836
GeneOntologyMolecularFunction	carboxylic acid transmembrane transporter activity	SLC38A2 SLC22A9 ABCC2 SLC2A1	2.88e-03	207	57	4	GO:0046943
GeneOntologyMolecularFunction	neurotransmitter receptor activity	GABRG2 GABRG3 CHRNB2	2.93e-03	100	57	3	GO:0030594
GeneOntologyMolecularFunction	organic acid transmembrane transporter activity	SLC38A2 SLC22A9 ABCC2 SLC2A1	2.94e-03	208	57	4	GO:0005342
GeneOntologyMolecularFunction	xenobiotic transmembrane transporter activity	ABCC2 SLC2A1	4.24e-03	34	57	2	GO:0042910
GeneOntologyBiologicalProcess	G protein-coupled receptor signaling pathway	FZD6 OR5D16 OR10AG1 OR4K2 GPR50 P2RY12 CCR9 OR9Q1 OR1A2 GPRC6A SMIM17 OR4B1 OR8U3 PDE10A GABBR2 OR8B2 PSAPL1 OR10T2 GPR176 GPR139 GDE1 OR1L4 OR8G1	1.41e-12	1395	59	23	GO:0007186
GeneOntologyBiologicalProcess	detection of chemical stimulus involved in sensory perception of smell	OR5D16 OR10AG1 OR4K2 OR9Q1 OR1A2 SMIM17 OR4B1 OR8U3 OR8B2 OR10T2 OR1L4 OR8G1	2.81e-09	432	59	12	GO:0050911
GeneOntologyBiologicalProcess	sensory perception of smell	OR5D16 OR10AG1 OR4K2 OR9Q1 OR1A2 SMIM17 OR4B1 OR8U3 OR8B2 OR10T2 OR1L4 OR8G1	6.42e-09	465	59	12	GO:0007608
GeneOntologyBiologicalProcess	detection of chemical stimulus involved in sensory perception	OR5D16 OR10AG1 OR4K2 OR9Q1 OR1A2 SMIM17 OR4B1 OR8U3 OR8B2 OR10T2 OR1L4 OR8G1	1.02e-08	485	59	12	GO:0050907
GeneOntologyBiologicalProcess	detection of chemical stimulus	OR5D16 OR10AG1 OR4K2 OR9Q1 OR1A2 SMIM17 OR4B1 OR8U3 OR8B2 OR10T2 OR1L4 OR8G1	2.41e-08	524	59	12	GO:0009593
GeneOntologyBiologicalProcess	sensory perception of chemical stimulus	OR5D16 OR10AG1 OR4K2 OR9Q1 OR1A2 SMIM17 OR4B1 OR8U3 OR8B2 OR10T2 OR1L4 OR8G1	3.86e-08	547	59	12	GO:0007606
GeneOntologyBiologicalProcess	detection of stimulus involved in sensory perception	OR5D16 OR10AG1 OR4K2 OR9Q1 OR1A2 SMIM17 OR4B1 OR8U3 OR8B2 OR10T2 OR1L4 OR8G1	7.60e-08	582	59	12	GO:0050906
GeneOntologyBiologicalProcess	sensory perception	OR5D16 OR10AG1 OR4K2 LHFPL4 KCND2 OR9Q1 OR1A2 SMIM17 OR4B1 OR8U3 OR8B2 OR10T2 CHRNB2 OR1L4 OR8G1	2.29e-07	1072	59	15	GO:0007600
GeneOntologyBiologicalProcess	detection of stimulus	OR5D16 OR10AG1 OR4K2 OR9Q1 OR1A2 SMIM17 OR4B1 OR8U3 OR8B2 OR10T2 OR1L4 OR8G1	7.64e-07	722	59	12	GO:0051606
GeneOntologyBiologicalProcess	inhibitory synapse assembly	GABRG2 GABRG3 LHFPL4	8.54e-05	30	59	3	GO:1904862
GeneOntologyBiologicalProcess	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	P2RY12 GABBR2 PSAPL1 GPR176	1.08e-04	86	59	4	GO:0007193
GeneOntologyBiologicalProcess	transport across blood-brain barrier	SLC38A2 ABCC2 SLC29A2 SLC2A1	1.13e-04	87	59	4	GO:0150104
GeneOntologyBiologicalProcess	vascular transport	SLC38A2 ABCC2 SLC29A2 SLC2A1	1.18e-04	88	59	4	GO:0010232
GeneOntologyBiologicalProcess	gamma-aminobutyric acid signaling pathway	GABRG2 GABRG3 GABBR2	1.36e-04	35	59	3	GO:0007214
GeneOntologyBiologicalProcess	forebrain development	SLC38A2 NDNF P2RY12 NRG3 SLC2A1 CHRNB2 PHLPP2	4.74e-04	489	59	7	GO:0030900
GeneOntologyCellularComponent	GABA-ergic synapse	GABRG2 GABRG3 LHFPL4 KCND2 NXPH1 GABBR2	6.80e-06	164	59	6	GO:0098982
GeneOntologyCellularComponent	postsynaptic membrane	GABRG2 GABRG3 LHFPL4 ANK2 KCND2 GABBR2 AKAP1 CHRNB2	1.73e-05	405	59	8	GO:0045211
GeneOntologyCellularComponent	GABA receptor complex	GABRG2 GABRG3 GABBR2	2.74e-05	21	59	3	GO:1902710
GeneOntologyCellularComponent	synaptic membrane	GABRG2 GABRG3 LHFPL4 ANK2 KCND2 GABBR2 AKAP1 CHRNB2	2.21e-04	583	59	8	GO:0097060
GeneOntologyCellularComponent	postsynaptic specialization	GABRG2 LHFPL4 ANK2 GPR50 KCND2 AKAP1 CHRNB2	5.18e-04	503	59	7	GO:0099572
GeneOntologyCellularComponent	plasma membrane raft	P2RY12 KCND2 SLC2A1 CHRNB2	7.91e-04	147	59	4	GO:0044853
GeneOntologyCellularComponent	GABA-A receptor complex	GABRG2 GABRG3	1.30e-03	19	59	2	GO:1902711
GeneOntologyCellularComponent	cell projection membrane	GABRG2 GABRG3 P2RY12 ABCC2 CUBN PHLPP2	1.33e-03	431	59	6	GO:0031253
GeneOntologyCellularComponent	sarcolemma	SLC38A2 ANK2 KCND2 SLC2A1	2.04e-03	190	59	4	GO:0042383
GeneOntologyCellularComponent	postsynapse	GABRG2 GABRG3 LHFPL4 ANK2 GPR50 KCND2 GABBR2 AKAP1 CHRNB2	2.08e-03	1018	59	9	GO:0098794
GeneOntologyCellularComponent	apical plasma membrane	FZD6 ANK2 ABCC2 CUBN SLC29A2 SLC2A1	2.46e-03	487	59	6	GO:0016324
GeneOntologyCellularComponent	basal plasma membrane	SLC22A9 ANK2 P2RY12 SLC29A2 SLC2A1	3.21e-03	354	59	5	GO:0009925
GeneOntologyCellularComponent	inhibitory synapse	GABRG2 LHFPL4	3.45e-03	31	59	2	GO:0060077
GeneOntologyCellularComponent	caveola	P2RY12 KCND2 SLC2A1	3.82e-03	111	59	3	GO:0005901
GeneOntologyCellularComponent	synaptic cleft	NXPH1 EGFLAM	3.91e-03	33	59	2	GO:0043083
GeneOntologyCellularComponent	basal part of cell	SLC22A9 ANK2 P2RY12 SLC29A2 SLC2A1	4.24e-03	378	59	5	GO:0045178
GeneOntologyCellularComponent	monoatomic ion channel complex	GABRG2 GABRG3 KCND2 CCDC51 CHRNB2	4.24e-03	378	59	5	GO:0034702
GeneOntologyCellularComponent	transporter complex	GABRG2 GABRG3 KCND2 CCDC51 SLC2A1 CHRNB2	4.47e-03	550	59	6	GO:1990351
HumanPheno	Hyperventilation	GABRG2 GABBR2 SLC2A1 CHRNB2	7.97e-06	41	17	4	HP:0002883
HumanPheno	EEG with focal epileptiform discharges	GABRG2 HID1 GABBR2 SLC2A1 CHRNB2	3.03e-05	118	17	5	HP:0011185
HumanPheno	Limb myoclonus	GABRG2 GABBR2 SLC2A1	1.07e-04	29	17	3	HP:0045084
HumanPheno	Punding	GABRG2 SLC2A1	1.56e-04	6	17	2	HP:0030218
HumanPheno	EEG with abnormally slow frequencies	GABRG2 HID1 GABBR2 SLC2A1	1.67e-04	88	17	4	HP:0011203
HumanPheno	Uncontrolled eye movements	GABRG2 SLC2A1	2.90e-04	8	17	2	HP:0007738
HumanPheno	EEG with spike-wave complexes (2.5-3.5 Hz)	GABRG2 SLC2A1	2.90e-04	8	17	2	HP:0010848
MousePheno	impaired passive avoidance behavior	GABBR2 SLC2A1 CHRNB2	1.22e-04	34	40	3	MP:0004000
MousePheno	increased locomotor activity	GABRG2 GABBR2 UNC79 SLC2A1 CHRNB2	1.45e-04	178	40	5	MP:0031391
MousePheno	abnormal avoidance learning behavior	PDE10A GABBR2 SLC2A1 CHRNB2	1.46e-04	94	40	4	MP:0001462
MousePheno	impaired avoidance learning behavior	GABBR2 SLC2A1 CHRNB2	2.31e-04	42	40	3	MP:0012312
MousePheno	abnormal nervous system electrophysiology	GABRG2 PDE10A GABBR2 SLC2A1 GPR139 CHRNB2	3.17e-04	329	40	6	MP:0002272
MousePheno	decreased fear-related response	GABBR2 SLC2A1 CHRNB2	3.23e-04	47	40	3	MP:0003460
MousePheno	increased miniature inhibitory postsynaptic current frequency	GABRG2 LHFPL4	4.32e-04	11	40	2	MP:0014382
MousePheno	abnormal passive avoidance behavior	GABBR2 SLC2A1 CHRNB2	5.14e-04	55	40	3	MP:0002799
MousePheno	enhanced spatial learning	ANK2 CHRNB2	5.17e-04	12	40	2	MP:0012306
Domain	GPCR_Rhodpsn_7TM	OR5D16 OR10AG1 OR4K2 GPR50 P2RY12 CCR9 OR9Q1 OR1A2 OR4B1 OR8U3 OR8B2 OR10T2 GPR176 GPR139 OR1L4 OR8G1	9.27e-11	670	57	16	IPR017452
Domain	7tm_1	OR5D16 OR10AG1 OR4K2 GPR50 P2RY12 CCR9 OR9Q1 OR1A2 OR4B1 OR8U3 OR8B2 OR10T2 GPR176 GPR139 OR1L4 OR8G1	1.08e-10	677	57	16	PF00001
Domain	G_PROTEIN_RECEP_F1_1	OR5D16 OR10AG1 OR4K2 GPR50 P2RY12 CCR9 OR9Q1 OR1A2 OR4B1 OR8U3 OR8B2 OR10T2 GPR176 GPR139 OR1L4 OR8G1	1.28e-10	685	57	16	PS00237
Domain	G_PROTEIN_RECEP_F1_2	OR5D16 OR10AG1 OR4K2 GPR50 P2RY12 CCR9 OR9Q1 OR1A2 OR4B1 OR8U3 OR8B2 OR10T2 GPR176 GPR139 OR1L4 OR8G1	1.46e-10	691	57	16	PS50262
Domain	GPCR_Rhodpsn	OR5D16 OR10AG1 OR4K2 GPR50 P2RY12 CCR9 OR9Q1 OR1A2 OR4B1 OR8U3 OR8B2 OR10T2 GPR176 GPR139 OR1L4 OR8G1	1.49e-10	692	57	16	IPR000276
Domain	Olfact_rcpt	OR5D16 OR10AG1 OR4K2 OR9Q1 OR1A2 OR4B1 OR8U3 OR8B2 OR10T2 OR1L4 OR8G1	2.41e-08	393	57	11	IPR000725
Domain	GABBAg_rcpt	GABRG2 GABRG3	2.74e-05	3	57	2	IPR005437
Domain	Neurotransmitter_ion_chnl_CS	GABRG2 GABRG3 CHRNB2	3.49e-04	45	57	3	IPR018000
Domain	Neur_chan_memb	GABRG2 GABRG3 CHRNB2	3.73e-04	46	57	3	PF02932
Domain	Neur_chan_LBD	GABRG2 GABRG3 CHRNB2	3.97e-04	47	57	3	PF02931
Domain	Neur_channel	GABRG2 GABRG3 CHRNB2	3.97e-04	47	57	3	IPR006201
Domain	Neur_chan_lig-bd	GABRG2 GABRG3 CHRNB2	3.97e-04	47	57	3	IPR006202
Domain	NEUROTR_ION_CHANNEL	GABRG2 GABRG3 CHRNB2	3.97e-04	47	57	3	PS00236
Domain	Neurotrans-gated_channel_TM	GABRG2 GABRG3 CHRNB2	3.97e-04	47	57	3	IPR006029
Domain	-	GABRG2 GABRG3 CHRNB2	3.97e-04	47	57	3	2.70.170.10
Domain	GPCR_3_CS	GPRC6A GABBR2	8.13e-04	14	57	2	IPR017979
Domain	GPCR_3	GPRC6A GABBR2	1.85e-03	21	57	2	IPR000337
Domain	G_PROTEIN_RECEP_F3_4	GPRC6A GABBR2	2.03e-03	22	57	2	PS50259
Domain	7tm_3	GPRC6A GABBR2	2.03e-03	22	57	2	PF00003
Domain	GPCR_3_C	GPRC6A GABBR2	2.03e-03	22	57	2	IPR017978
Domain	G_PROTEIN_RECEP_F3_2	GPRC6A GABBR2	2.03e-03	22	57	2	PS00980
Domain	G_PROTEIN_RECEP_F3_3	GPRC6A GABBR2	2.03e-03	22	57	2	PS00981
Domain	G_PROTEIN_RECEP_F3_1	GPRC6A GABBR2	2.03e-03	22	57	2	PS00979
Domain	GABAA/Glycine_rcpt	GABRG2 GABRG3	2.22e-03	23	57	2	IPR006028
Domain	ANF_receptor	GPRC6A GABBR2	5.69e-03	37	57	2	PF01094
Domain	ANF_lig-bd_rcpt	GPRC6A GABBR2	5.69e-03	37	57	2	IPR001828
Domain	Peripla_BP_I	GPRC6A GABBR2	6.31e-03	39	57	2	IPR028082
Domain	EGF	EGFLAM CUBN NRG3	6.73e-03	126	57	3	PF00008
Domain	MFS_dom	SLC22A9 SLC29A2 SLC2A1	7.97e-03	134	57	3	IPR020846
Pathway	REACTOME_OLFACTORY_SIGNALING_PATHWAY	OR5D16 OR10AG1 OR4K2 OR9Q1 OR1A2 OR4B1 OR8U3 OR8B2 OR10T2 OR1L4 OR8G1	8.88e-08	417	47	11	M4072
Pathway	KEGG_OLFACTORY_TRANSDUCTION	OR5D16 OR10AG1 OR4K2 OR9Q1 OR1A2 OR4B1 OR8U3 OR10T2 OR1L4 OR8G1	4.75e-07	389	47	10	M14091
Pathway	REACTOME_SENSORY_PERCEPTION	OR5D16 OR10AG1 OR4K2 OR9Q1 OR1A2 OR4B1 OR8U3 OR8B2 OR10T2 OR1L4 OR8G1	5.71e-06	636	47	11	M41834
Pathway	WP_GABA_RECEPTOR_SIGNALING	GABRG2 GABRG3 GABBR2	1.46e-04	31	47	3	M39369
Pathway	WP_GPCRS_NONODORANT	FZD6 GPR50 P2RY12 CCR9 GPRC6A GABBR2	2.39e-04	266	47	6	MM15843
Pathway	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES	GABRG2 SLC38A2 GABRG3 GABBR2 CHRNB2	6.59e-04	211	47	5	MM14502
Pathway	REACTOME_NEURONAL_SYSTEM	GABRG2 SLC38A2 GABRG3 KCND2 GABBR2 CHRNB2	8.13e-04	335	47	6	MM14503
Pathway	REACTOME_SIGNALING_BY_ERBB4	GABRG2 GABRG3 NRG3	9.42e-04	58	47	3	M544
Pathway	REACTOME_GABA_RECEPTOR_ACTIVATION	GABRG2 GABRG3 GABBR2	1.04e-03	60	47	3	M976
Pathway	REACTOME_GABA_RECEPTOR_ACTIVATION	GABRG2 GABRG3 GABBR2	1.04e-03	60	47	3	MM15708
Pubmed	Different evolutionary processes shaped the mouse and human olfactory receptor gene families.	OR5D16 OR10AG1 OR4K2 OR9Q1 OR1A2 SMIM17 OR4B1 OR8U3 OR8B2 OR1L4 OR8G1	1.79e-11	340	61	11	11875048
Pubmed	The olfactory receptor gene superfamily of the mouse.	OR5D16 OR10AG1 OR4K2 OR9Q1 OR1A2 SMIM17 OR4B1 OR8U3 OR8B2 OR1L4 OR8G1	1.79e-11	340	61	11	11802173
Pubmed	A unified nomenclature for vertebrate olfactory receptors.	OR5D16 OR10AG1 OR4K2 OR9Q1 OR1A2 SMIM17 OR4B1 OR8U3 OR8B2 OR1L4 OR8G1	1.97e-11	343	61	11	32295537
Pubmed	Odorant receptor expressed sequence tags demonstrate olfactory expression of over 400 genes, extensive alternate splicing and unequal expression levels.	OR5D16 OR10AG1 OR4K2 OR9Q1 OR1A2 SMIM17 OR4B1 OR8U3 OR8B2 OR1L4 OR8G1	2.16e-11	346	61	11	14611657
Pubmed	The human olfactory receptor gene family.	OR5D16 OR10AG1 OR4K2 OR1A2 OR4B1 OR8U3 OR8B2 OR10T2 OR1L4 OR8G1	3.38e-08	541	61	10	14983052
Pubmed	DEFOG: a practical scheme for deciphering families of genes.	OR5D16 OR9Q1 OR1A2 OR4B1 OR8B2 OR1L4 OR8G1	1.17e-07	219	61	7	12213199
Pubmed	Establishment and Dysfunction of the Blood-Brain Barrier.	SLC38A2 ABCC2 SLC29A2 SLC2A1	2.18e-06	52	61	4	26590417
Pubmed	Postsynaptic clustering of gamma-aminobutyric acid type A receptors by the gamma3 subunit in vivo.	GABRG2 GABRG3	3.03e-06	2	61	2	10536013
Pubmed	GABA neurotransmitter signaling in the developing mouse lens: dynamic regulation of components and functionality.	GABRG2 GABRG3 GABBR2	4.11e-06	18	61	3	18985723
Pubmed	Contribution of Common Variants in GABRG2, RELN and NRG3 and Interaction Networks to the Risk of Hirschsprung Disease.	GABRG2 NRG3	9.07e-06	3	61	2	27889765
Pubmed	An immunohistochemical study of GABA A receptor gamma subunits in Alzheimer's disease hippocampus: relationship to neurofibrillary tangle progression.	GABRG2 GABRG3	9.07e-06	3	61	2	19019179
Pubmed	GARLH Family Proteins Stabilize GABAA Receptors at Synapses.	GABRG2 LHFPL4	9.07e-06	3	61	2	28279354
Pubmed	Subunit specificity and interaction domain between GABA(A) receptor-associated protein (GABARAP) and GABA(A) receptors.	GABRG2 GABRG3	1.81e-05	4	61	2	11948245
Pubmed	Hetero-oligomerization between GABAA and GABAB receptors regulates GABAB receptor trafficking.	GABRG2 GABBR2	1.81e-05	4	61	2	14966130
Pubmed	Interaction of calcineurin and type-A GABA receptor gamma 2 subunits produces long-term depression at CA1 inhibitory synapses.	GABRG2 GABRG3	3.02e-05	5	61	2	12574411
Pubmed	An Essential Role for the Tetraspanin LHFPL4 in the Cell-Type-Specific Targeting and Clustering of Synaptic GABAA Receptors.	GABRG2 LHFPL4	3.02e-05	5	61	2	28978485
Pubmed	Blood-Brain Barrier: From Physiology to Disease and Back.	SLC38A2 ABCC2 SLC29A2 SLC2A1	3.59e-05	105	61	4	30280653
Pubmed	Independent assembly and subcellular targeting of GABA(A)-receptor subtypes demonstrated in mouse hippocampal and olfactory neurons in vivo.	GABRG2 GABRG3	4.52e-05	6	61	2	9682826
Pubmed	Impairment of Inhibitory Synapse Formation and Motor Behavior in Mice Lacking the NL2 Binding Partner LHFPL4/GARLH4.	GABRG2 LHFPL4	4.52e-05	6	61	2	29742426
Pubmed	Genome-wide association study indicates variants associated with insulin signaling and inflammation mediate lipoprotein responses to fenofibrate.	NXPH1 PDE10A	6.32e-05	7	61	2	22890011
Pubmed	Identification of G protein-coupled receptor genes from the human genome sequence.	P2RY12 GPRC6A GPR139	7.38e-05	46	61	3	12044878
Pubmed	Altered placental function of 11beta-hydroxysteroid dehydrogenase 2 knockout mice.	SLC38A2 SLC2A1	1.08e-04	9	61	2	18845627
Pubmed	Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway.	CUBN GABBR2	1.08e-04	9	61	2	19744961
Pubmed	Variation at the GABAA receptor gene, Rho 1 (GABRR1) associated with susceptibility to bipolar schizoaffective disorder.	GABRG2 GABRG3	1.35e-04	10	61	2	20583128
Pubmed	γ1 GABAA Receptors in Spinal Nociceptive Circuits.	GABRG2 GABRG3	1.65e-04	11	61	2	39137998
Pubmed	Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment.	GABRG2 GABRG3 NRG3 GABBR2 CHRNB2	1.85e-04	300	61	5	19086053
Pubmed	Identification of ligands for olfactory receptors by functional expression of a receptor library.	OR1A2 OR8G1	1.97e-04	12	61	2	9875846
Pubmed	Molecular physiology of renal organic anion transporters.	SLC22A9 ABCC2	2.33e-04	13	61	2	16403838
Pubmed	Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins.	FZD6 SLC38A2 LPGAT1 UBAC2 GPR176 SLC2A1	2.41e-04	499	61	6	22810586
Pubmed	Odorant and vomeronasal receptor genes in two mouse genome assemblies.	OR1A2 OR4B1 OR8G1	3.05e-04	74	61	3	15081110
Pubmed	Tissue distribution, ontogeny, and hormonal regulation of xenobiotic transporters in mouse kidneys.	SLC22A9 SLC29A2	3.57e-04	16	61	2	19679677
Pubmed	Placental and fetal characteristics of the Ohia mouse line recapitulate outcomes in human hypoplastic left heart syndrome.	SLC38A2 SLC2A1	3.57e-04	16	61	2	34890862
Pubmed	The G protein-coupled receptor repertoires of human and mouse.	GABBR2 GPR176 GPR139	3.69e-04	79	61	3	12679517
Pubmed	An approach based on a genome-wide association study reveals candidate loci for narcolepsy.	AKAP1 OR10T2 GPR176 CHRNB2	3.75e-04	193	61	4	20677014
Pubmed	Tlx1/3 and Ptf1a control the expression of distinct sets of transmitter and peptide receptor genes in the developing dorsal spinal cord.	GABRG2 GABRG3 GABBR2	3.97e-04	81	61	3	22723691
Pubmed	Complex patterns of cell growth in the placenta in normal pregnancy and as adaptations to maternal diet restriction.	SLC38A2 SLC2A1	4.55e-04	18	61	2	31917811
Pubmed	Genome-wide Analysis of RARβ Transcriptional Targets in Mouse Striatum Links Retinoic Acid Signaling with Huntington's Disease and Other Neurodegenerative Disorders.	GABRG3 PDE10A	4.55e-04	18	61	2	27405468
Pubmed	Spatial and temporal analysis of gene expression during growth and fusion of the mouse facial prominences.	NDNF GPR50	4.55e-04	18	61	2	20016822
Pubmed	Comparative human/murine sequence analysis of the common eliminated region 1 from human 3p21.3.	CCR9 LRRC2	4.55e-04	18	61	2	12461651
Pubmed	Kv7/KCNQ potassium channels in cortical hyperexcitability and juvenile seizure-related death in Ank2-mutant mice.	GABRG2 ANK2	4.55e-04	18	61	2	37321992
Pubmed	Ecm29-mediated proteasomal distribution modulates excitatory GABA responses in the developing brain.	GABRG2 ANK2	4.55e-04	18	61	2	31910261
Pubmed	Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype.	GABRG2 GABRG3	4.55e-04	18	61	2	19078961
Pubmed	PRDM16 determines specification of ventricular cardiomyocytes by suppressing alternative cell fates.	ANK2 KCND2	6.22e-04	21	61	2	39304345
Pubmed	Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis.	FZD6 SLC2A1	6.22e-04	21	61	2	19129494
Pubmed	Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality.	NRG3 SLC2A1	6.83e-04	22	61	2	21348951
Pubmed	Identification of new ciliary signaling pathways in the brain and insights into neurological disorders.	GABRG2 KCND2 PDE10A GABBR2 SLC2A1	7.28e-04	405	61	5	38187761
Pubmed	Specific repertoire of olfactory receptor genes in the male germ cells of several mammalian species.	OR4B1 OR8G1	8.15e-04	24	61	2	9119360
Pubmed	TNF deficiency causes alterations in the spatial organization of neurogenic zones and alters the number of microglia and neurons in the cerebral cortex.	FZD6 SLC2A1	1.03e-03	27	61	2	31505254
Pubmed	Integrated Morphoelectric and Transcriptomic Classification of Cortical GABAergic Cells.	NDNF GPR139	1.03e-03	27	61	2	33186530
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	FZD6 SLC38A2 GTF3C1 LPGAT1 UBAC2 AKAP1 GDE1 TANGO6	1.15e-03	1201	61	8	35696571
Pubmed	Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature.	FZD6 SLC2A1	1.19e-03	29	61	2	19023080
Pubmed	Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.	ANK2 NXPH1	1.28e-03	30	61	2	20080650
Pubmed	Scaled, high fidelity electrophysiological, morphological, and transcriptomic cell characterization.	NDNF GPR139	1.45e-03	32	61	2	34387544
Pubmed	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	NRG3 AGBL1	1.54e-03	33	61	2	24204828
Pubmed	Genetical genomic determinants of alcohol consumption in rats and humans.	GABRG2 GABRG3 CHRNB2	1.57e-03	130	61	3	19874574
Pubmed	Cell Surface Proteomic Map of HIV Infection Reveals Antagonism of Amino Acid Metabolism by Vpu and Nef.	FZD6 SLC38A2 SLC29A2	1.64e-03	132	61	3	26439863
Cytoband	10q22-q23	BTAF1 NRG3	1.73e-05	5	61	2	10q22-q23
Cytoband	Ensembl 112 genes in cytogenetic band chr11q12	OR5D16 SLC22A9 OR10AG1 OR9Q1 OR8U3	9.81e-05	345	61	5	chr11q12
Cytoband	Ensembl 112 genes in cytogenetic band chr3p21	CCR9 LRRC2 CCDC51 DNAH1	8.44e-04	316	61	4	chr3p21
Cytoband	Ensembl 112 genes in cytogenetic band chr16p12	GTF3C1 GPR139 GDE1	1.59e-03	172	61	3	chr16p12
Cytoband	11q11	OR5D16 OR10AG1	1.81e-03	47	61	2	11q11
GeneFamily	Solute carriers	SLC38A2 SLC22A9 SLC35B4 SLC35E3 SLC29A2 SLC2A1	2.14e-04	395	40	6	752
GeneFamily	G protein-coupled receptors, Class A orphans	GPR50 GPR176 GPR139	6.80e-04	78	40	3	262
GeneFamily	Gamma-aminobutyric acid type A receptor subunits	GABRG2 GABRG3	7.97e-04	19	40	2	563
GeneFamily	Olfactory receptors, family 1	OR1A2 OR1L4	3.53e-03	40	40	2	147
GeneFamily	Olfactory receptors, family 8	OR8B2 OR8G1	5.26e-03	49	40	2	155
GeneFamily	Olfactory receptors, family 10	OR10AG1 OR10T2	9.36e-03	66	40	2	157
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA1	GABRG2 LHFPL4 ANK2 KCND2 FAM169A SMIM17 GABBR2 UNC79 GPR176	2.77e-06	584	54	9	M39068
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBGABA	GABRG2 LHFPL4 ANK2 KCND2 FAM169A GABBR2 AKAP1 UNC79 GPR176	1.23e-05	703	54	9	M39070
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HSERT	GABRG2 LHFPL4 ANK2 SMIM17 GABBR2 UNC79 GPR176	3.70e-05	450	54	7	M39072
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HRN	GABRG2 LHFPL4 ANK2 KCND2 LPGAT1 UNC79	6.42e-05	335	54	6	M39065
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	GABRG2 LHFPL4 ANK2 NXPH1 FAM169A LRRC2 SMIM17 GABBR2 UNC79 GPR176	7.57e-05	1106	54	10	M39071
ToppCell	Posterior_cortex-Neuronal\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	GABRG2 LHFPL4 FAM169A NRG3 GABBR2 CHRNB2	2.38e-07	193	60	6	b4989e3436e84dbec3789b46057e0f7a0ebf09d4
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GABRG2 GABRG3 KCND2 NRG3 GABBR2 UNC79	2.77e-07	198	60	6	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GABRG2 GABRG3 KCND2 NRG3 GABBR2 UNC79	2.77e-07	198	60	6	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GABRG2 GABRG3 KCND2 NRG3 GABBR2 UNC79	2.77e-07	198	60	6	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	Cerebellum-Neuronal\|Cerebellum / BrainAtlas - Mouse McCarroll V32	GABRG2 FAM169A NRG3 UNC79 CHRNB2	5.33e-06	187	60	5	61b9d6eb131a674598aa8409d7fa909c8765442d
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GABRG2 GABRG3 NRG3 GABBR2 UNC79	6.70e-06	196	60	5	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GABRG2 GABRG3 NRG3 GABBR2 UNC79	7.04e-06	198	60	5	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GABRG2 GABRG3 NRG3 GABBR2 UNC79	7.04e-06	198	60	5	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GABRG2 GABRG3 NDNF HID1 GABBR2	7.39e-06	200	60	5	2f481e2fd248c02a5aa2e0248c16808df142fed2
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GABRG2 GABRG3 NDNF HID1 GABBR2	7.39e-06	200	60	5	dc674124475edf83908b51a4e1454bc2dc4f06fa
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GABRG2 GABRG3 NDNF HID1 GABBR2	7.39e-06	200	60	5	bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	GABRG2 GABRG3 NRG3 GABBR2 UNC79	7.39e-06	200	60	5	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	COVID-19-kidney-Mito-rich_Int\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GABRG2 GABRG3 OR4K2 NXPH1	2.23e-05	122	60	4	a4220adb4e6055a599bd9bbf65d460fc4e68b543
ToppCell	COVID-19-kidney-Epithelial_(EC)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GABRG2 GABRG3 OR10AG1 NRG3	3.13e-05	133	60	4	a8abb6b54862123961ae6defbf251ee6e9575258
ToppCell	COVID-19-kidney-Technical/muscle\|kidney / Disease (COVID-19 only), tissue and cell type	GABRG3 KCND2 NXPH1 AGBL1	4.75e-05	148	60	4	0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GABRG2 GABRG3 NXPH1 AGBL1	4.75e-05	148	60	4	d6ac5972267254651dfbe16bb4e9a62228093cc7
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Mucinous_Carcinoma-1\|TCGA-Breast / Sample_Type by Project: Shred V9	GABRG2 KCND2 UNC79 CHRNB2	4.88e-05	149	60	4	649eb3441fa859591ea85f1ed5fcf08af272a32b
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	GABRG3 KCND2 GABBR2 AGBL1	6.28e-05	159	60	4	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NDNF SLC35E3 CUBN GDE1	6.75e-05	162	60	4	34b4cd3d2258f88dfbd6d32abd1db87aff8a6b6f
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	GABRG3 EGFLAM GABBR2 AGBL1	6.91e-05	163	60	4	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NDNF SLC35E3 CUBN GDE1	6.91e-05	163	60	4	56b8668dbf06faa6866ec71f29b92907b73f074d
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRG2 GABRG3 SMIM17 CHRNB2	7.42e-05	166	60	4	548d0d6c0ffd564036ddba78620734220ebb73d7
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRG2 GABRG3 SMIM17 CHRNB2	7.42e-05	166	60	4	80e164a89d22098cabe4a99a78283ba69ea0561e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GABRG3 CUBN GABBR2 AGBL1	7.59e-05	167	60	4	3edb0570e583bb527165bcd8a4c25a042054043b
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GABRG2 CFAP74 UNC79 GPR176	7.95e-05	169	60	4	606aa4ff25380d9470ec116ca86cd20f8b19587a
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GABRG2 CFAP74 UNC79 GPR176	7.95e-05	169	60	4	052aae2af5446a0de071d5dda5381b0b9a0ed54d
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC38A2 LPGAT1 GABBR2 CHRNB2	8.90e-05	174	60	4	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Adult / Lineage, Cell type, age group and donor	LHFPL4 ANK2 KCND2 UNC79	9.10e-05	175	60	4	4db1a3c284488b3f6de7568363f176d74e2a4587
ToppCell	Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231\|Adult / Lineage, Cell type, age group and donor	LHFPL4 ANK2 KCND2 UNC79	9.10e-05	175	60	4	8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10\|TCGA-Colorectal / Sample_Type by Project: Shred V9	KCND2 TNFSF8 EGFLAM GPR176	9.93e-05	179	60	4	cc079ba015326dccde955c5eafa3e4a2e40de192
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANK2 KCND2 GPR176 CHRNB2	1.06e-04	182	60	4	be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1
ToppCell	Substantia_nigra-Neuronal\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	GABRG2 SMIM17 UNC79 CHRNB2	1.15e-04	186	60	4	3f889083fcffe516388e9b03a5e23af2010ced33
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-Granular_Neuron_CB_Gabra6\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRG2 FAM169A UNC79 CHRNB2	1.15e-04	186	60	4	d6c8ce2a32c218dcc63d861cc247152430ed3c8c
ToppCell	Substantia_nigra-Neuronal-Inhibitory\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	GABRG2 SMIM17 UNC79 CHRNB2	1.15e-04	186	60	4	9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce
ToppCell	5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LHFPL4 ANK2 KCND2 GPR176	1.22e-04	189	60	4	cceca3d14dd559bbb2cb4b81ea12c2b62d18ee49
ToppCell	wk_08-11-Epithelial-Proximal_epithelial-intermediate_neuroendocrine\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	GABRG2 ANK2 UNC79 CHRNB2	1.25e-04	190	60	4	5f1863bce9400b7c932f0e4d0e012ec4e8d7e555
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GABRG3 ANK2 PDE10A GPR176	1.25e-04	190	60	4	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-FDC\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GABRG3 ANK2 GABBR2 SLC2A1	1.35e-04	194	60	4	f9fbb043411546d8c9e0321a64165d411f44aeb7
ToppCell	Hippocampus-Neuronal\|Hippocampus / BrainAtlas - Mouse McCarroll V32	FAM169A NRG3 GABBR2 CHRNB2	1.35e-04	194	60	4	8aeb347b3024354c9505f4f0fddf0b843489dc6b
ToppCell	Bronchial-NucSeq-Stromal-Peri/Epineurial_\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK2 PDE10A PSAPL1 SLC2A1	1.44e-04	197	60	4	ee8f7def9d5af7b1e636830a4ea1da158d02f25a
ToppCell	wk_08-11-Epithelial-Distal_epithelial_progenitor\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	TNFSF8 SLC35B4 HID1 SLC2A1	1.46e-04	198	60	4	eda85a592527992b51a00f288cff0c3239c47e6f
ToppCell	wk_08-11-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	TNFSF8 SLC35B4 HID1 SLC2A1	1.46e-04	198	60	4	84697f316d9195ebe838cf57f4dbdd9feea43bec
ToppCell	Sepsis-ICU-NoSEP-Lymphocyte-T/NK-dn_T\|ICU-NoSEP / Disease, condition lineage and cell class	FZD6 LHFPL4 GTF3C1 CUBN	1.49e-04	199	60	4	7fb211f803a8b3a2cfa9455386abea08131c6b52
ToppCell	Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	BTAF1 CCDC51 AKAP1 SLC2A1	1.52e-04	200	60	4	be46efc899d06c55ee297bee3126f69bcdb2048b
Computational	Ion channels.	GABRG2 GABRG3 CHRNB2	2.42e-05	27	23	3	MODULE_214
Drug	TBPS	GABRG2 GABRG3 GTF3C1 BTAF1 GABBR2	2.83e-06	87	58	5	CID000104781
Drug	alpha IMGBL	GABRG2 GABRG3 GABBR2	4.41e-06	13	58	3	CID000131516
Drug	ivermectin	GABRG2 GABRG3 ABCC2 GABBR2 CHRNB2	5.91e-06	101	58	5	CID006435110
Drug	clorazepate	GABRG2 GABRG3 GABBR2	1.25e-05	18	58	3	CID000002809
Drug	ZK 93426	GABRG2 GABRG3 GABBR2	1.48e-05	19	58	3	CID000115210
Drug	2-hydroxysaclofen	GABRG2 GABRG3 GABBR2 SLC2A1	1.55e-05	59	58	4	CID000001564
Drug	EBOB	GABRG2 GABRG3 GABBR2	1.73e-05	20	58	3	CID000115223
Drug	prazepam	GABRG2 GABRG3 GABBR2	2.02e-05	21	58	3	CID000004890
Drug	bicuculline methochloride	GABRG2 GABRG3 GABBR2	2.02e-05	21	58	3	CID000123659
Drug	R 5135	GABRG2 GABRG3 GABBR2	2.02e-05	21	58	3	CID000119544
Drug	AC1L1J7N	GABRG2 GABRG3 ANK2 GABBR2	2.15e-05	64	58	4	CID000004902
Drug	imidazenil	GABRG2 GABRG3 GABBR2	2.33e-05	22	58	3	CID000119194
Drug	zolazepam	GABRG2 GABRG3 GABBR2	2.68e-05	23	58	3	CID000035775
Drug	gamma-acetylenic GABA	GABRG2 GABRG3 GABBR2	3.06e-05	24	58	3	CID000003452
Drug	medazepam	GABRG2 GABRG3 GABBR2	3.06e-05	24	58	3	CID000004041
Drug	SL 75102	GABRG2 GABRG3 GABBR2	3.06e-05	24	58	3	CID005751746
Drug	phaclofen	GABRG2 GABRG3 GABBR2 SLC2A1	3.07e-05	70	58	4	CID000001641
Drug	benzodiazepine	GABRG2 GABRG3 GABBR2 SLC29A2 CHRNB2	3.09e-05	142	58	5	CID000134664
Drug	isonipecotic acid	GABRG2 GABRG3 GABBR2	3.47e-05	25	58	3	CID000003773
Drug	P4-s	GABRG2 GABRG3 GABBR2	3.47e-05	25	58	3	CID000004838
Drug	beta-CCE	GABRG2 GABRG3 GABBR2	3.47e-05	25	58	3	CID000105078
Drug	SKF97541	GABRG2 GABRG3 GABBR2	3.91e-05	26	58	3	CID000005230
Drug	V-X-A	GABRG2 GABRG3 GABBR2	3.91e-05	26	58	3	CID006369389
Drug	pitrazepin	GABRG2 GABRG3 GABBR2	4.39e-05	27	58	3	CID000146222
Drug	chlormethiazole	GABRG2 GABRG3 GABBR2	4.91e-05	28	58	3	CID000010783
Drug	mephobarbital	GABRG2 GABRG3 GABBR2	4.91e-05	28	58	3	CID000008271
Drug	etazolate	GABRG2 GABRG3 GABBR2	5.47e-05	29	58	3	CID000003277
Drug	guvacine	GABRG2 GABRG3 GABBR2	6.07e-05	30	58	3	CID000003532
Drug	allylglycine	GABRG2 GABRG3 GABBR2	6.07e-05	30	58	3	CID000014044
Drug	AC1NRA7B	ABCC2 SLC2A1	6.35e-05	5	58	2	CID005287741
Drug	SKF89976A	GABRG2 GABRG3 GABBR2	6.70e-05	31	58	3	CID000092409
Drug	clozapine	GABRG2 GABRG3 KCND2 NRG3 GABBR2 CHRNB2	6.89e-05	274	58	6	CID000002818
Drug	neostigmine	GABRG2 GABRG3 GABBR2 CHRNB2	7.21e-05	87	58	4	CID000004456
Drug	dehydroepiandrosterone sulfate	GABRG2 SLC38A2 GABRG3 SLC22A9 P2RY12 GABBR2	7.31e-05	277	58	6	CID000005244
Drug	homotaurine	GABRG2 GABRG3 GABBR2	7.38e-05	32	58	3	CID000001646
Drug	3-aminopropylphosphinic acid	GABRG2 GABRG3 GABBR2	7.38e-05	32	58	3	CID006335948
Drug	CGS 8216	GABRG2 GABRG3 GABBR2	8.11e-05	33	58	3	CID000104916
Drug	AC1L2FYN	GABRG2 GABRG3 GABBR2	8.11e-05	33	58	3	CID000071333
Drug	amobarbital	GABRG2 GABRG3 GABBR2	8.88e-05	34	58	3	CID000002163
Drug	temazepam	GABRG2 GABRG3 GABBR2	8.88e-05	34	58	3	CID000005391
Drug	methylone	GABRG2 GABBR2	9.50e-05	6	58	2	ctd:C400939
Drug	estazolam	GABRG2 GABRG3 GABBR2	9.69e-05	35	58	3	CID000003261
Drug	flurazepam	GABRG2 GABRG3 GABBR2	9.69e-05	35	58	3	CID000003393
Drug	FG 7142	GABRG2 GABRG3 GABBR2	1.06e-04	36	58	3	CID000004375
Drug	secobarbital	GABRG2 GABRG3 GABBR2	1.15e-04	37	58	3	CID000005193
Drug	sodium	GABRG2 SLC38A2 GABRG3 ANK2 KCND2 ABCC2 GABBR2 SLC29A2 SLC2A1 CHRNB2	1.22e-04	944	58	10	CID000000923
Drug	DMCM	GABRG2 GABRG3 GABBR2	1.24e-04	38	58	3	CID000104999
Drug	alprazolam	GABRG2 GABRG3 PDE10A GABBR2 CHRNB2	1.32e-04	193	58	5	CID000002118
Drug	3,5-dibromo-2-(2,4-dibromophenoxy)phenol	GABRG2 CHRNB2	1.33e-04	7	58	2	ctd:C085794
Drug	zaleplon	GABRG2 GABRG3 GABBR2	1.34e-04	39	58	3	CID000005719
Drug	beta-alanine	GABRG2 SLC38A2 GABRG3 GABBR2	1.44e-04	104	58	4	CID000000239
Drug	Gabrene	GABRG2 GABRG3 GABBR2	1.45e-04	40	58	3	CID005361323
Drug	gaboxadol	GABRG2 GABRG3 GABBR2	1.56e-04	41	58	3	CID000003448
Drug	CGP55845	GABRG2 GABRG3 GABBR2	1.56e-04	41	58	3	CID000123885
Drug	Pyrazinamide [ 98-96-4]; Up 200; 32.4uM; PC3; HT_HG-U133A	NDNF ANK2 CCR9 SLC2A1 CHRNB2	1.56e-04	200	58	5	6617_UP
Drug	midazolam	GABRG2 GABRG3 GABBR2 CHRNB2	1.61e-04	107	58	4	CID000004192
Drug	barbital	GABRG2 GABRG3 GABBR2	1.68e-04	42	58	3	CID000002294
Drug	Niflumic Acid	GABRG2 SLC2A1 CHRNB2	1.68e-04	42	58	3	ctd:D009544
Drug	zolpidem	GABRG2 GABRG3 GABBR2	1.80e-04	43	58	3	CID000005732
Drug	saclofen	GABRG2 GABRG3 GABBR2	1.93e-04	44	58	3	CID000122150
Drug	lorazepam	GABRG2 GABRG3 GABBR2	1.93e-04	44	58	3	CID000003958
Drug	CGP 36742	GABRG2 GABRG3 GABBR2	1.93e-04	44	58	3	CID000130021
Drug	gamma-aminobutyric acid	GABRG2 SLC38A2 GABRG3 CFAP74 GPRC6A GABBR2 CHRNB2	1.95e-04	474	58	7	CID000000119
Drug	isoguvacine	GABRG2 GABRG3 GABBR2	2.06e-04	45	58	3	CID000003765
Drug	TPMPA	GABRG2 GABRG3 GABBR2	2.06e-04	45	58	3	CID000005520
Drug	forskolin from Coleus forskohlii	GABRG2 SLC38A2 GABRG3 P2RY12 KCND2 PDE10A GABBR2 AKAP1 SLC2A1 CHRNB2	2.17e-04	1013	58	10	CID000003413
Drug	heptachlor epoxide	GABRG2 GABRG3 GABBR2	2.20e-04	46	58	3	CID000013930
Drug	delta-aminovaleric acid	GABRG2 GABRG3 GABBR2	2.35e-04	47	58	3	CID000000138
Drug	nitrazepam	GABRG2 GABRG3 GABBR2	2.35e-04	47	58	3	CID000004506
Drug	flurothyl	GABRG2 GABRG3 GABBR2	2.35e-04	47	58	3	CID000009528
Drug	N-methyl-DL-aspartic acid	GABRG2 GABRG3 KCND2 NRG3 PDE10A GABBR2 SLC2A1 CHRNB2	2.42e-04	655	58	8	CID000004376
Drug	Calcium	NOX1 CCR9 ABCC2 GABBR2 AKAP1 SLC2A1 CHRNB2	2.48e-04	493	58	7	ctd:D002118
Drug	imidazole-4-acetic acid	GABRG2 GABRG3 GABBR2	2.50e-04	48	58	3	CID000096215
Drug	pentobarbital	GABRG2 GABRG3 GABBR2 SLC2A1 CHRNB2	2.64e-04	224	58	5	CID000004737
Drug	thiamylal	GABRG2 GABRG3 GABBR2	2.66e-04	49	58	3	CID003032285
Drug	vigabatrin	GABRG2 GABRG3 GABBR2	2.66e-04	49	58	3	CID000005665
Drug	kynurenic acid	GABRG2 GABRG3 GABBR2 CHRNB2	2.66e-04	122	58	4	CID000003845
Drug	taurine	GABRG2 SLC38A2 GABRG3 ABCC2 GABBR2	3.04e-04	231	58	5	CID000001123
Drug	oxazepam	GABRG2 GABRG3 GABBR2	3.36e-04	53	58	3	CID000004616
Drug	fosazepam	GABRG2 GABRG3	3.46e-04	11	58	2	CID000037114
Drug	C19H18ClN3O	GABRG2 GABRG3	3.46e-04	11	58	2	CID000027452
Drug	flutoprazepam	GABRG2 GABRG3	3.46e-04	11	58	2	CID000003400
Drug	Arfendazam	GABRG2 GABRG3	3.46e-04	11	58	2	CID000065803
Drug	camazepam	GABRG2 GABRG3	3.46e-04	11	58	2	CID000037367
Drug	triflubazam	GABRG2 GABRG3	3.46e-04	11	58	2	CID000031157
Drug	Bu-1014	GABRG2 GABRG3	3.46e-04	11	58	2	CID015942721
Drug	Zapizolam	GABRG2 GABRG3	3.46e-04	11	58	2	CID000068832
Drug	Reclazepam	GABRG2 GABRG3	3.46e-04	11	58	2	CID003052777
Drug	iclazepam	GABRG2 GABRG3	3.46e-04	11	58	2	CID000068777
Drug	menitrazepam	GABRG2 GABRG3	3.46e-04	11	58	2	CID000189875
Drug	NSC 403654	GABBR2 SLC29A2	3.46e-04	11	58	2	CID000009319
Drug	Serin hydrazid	GABRG2 GABRG3	3.46e-04	11	58	2	CID000041637
Drug	sulazepam	GABRG2 GABRG3	3.46e-04	11	58	2	CID000017931
Drug	elfazepam	GABRG2 GABRG3	3.46e-04	11	58	2	CID000065445
Drug	uldazepam	GABRG2 GABRG3	3.46e-04	11	58	2	CID000034274
Drug	gidazepam	GABRG2 GABRG3	3.46e-04	11	58	2	CID000121919
Drug	fletazepam	GABRG2 GABRG3	3.46e-04	11	58	2	CID000036834
Drug	triazolam	GABRG2 GABRG3 GABBR2	3.55e-04	54	58	3	CID000005556
Drug	flumazenil	GABRG2 GABRG3 GABBR2	3.55e-04	54	58	3	CID000003373
Drug	SB-205384	GABRG2 GABRG3	4.14e-04	12	58	2	CID000197690
Disease	EPILEPSY, CHILDHOOD ABSENCE, 1	GABRG2 SLC2A1	6.07e-05	6	60	2	C1838604
Disease	childhood absence epilepsy (is_implicated_in)	GABRG2 SLC2A1	1.13e-04	8	60	2	DOID:1825 (is_implicated_in)
Disease	macrophage inflammatory protein 1b measurement	GABRG2 CCR9 LRRC2 CCDC51	1.72e-04	136	60	4	EFO_0008219
Disease	superior temporal gyrus volume measurement	NXPH1 CUBN	6.80e-04	19	60	2	EFO_0010331
Disease	CCL4 measurement	CCR9 LRRC2	7.55e-04	20	60	2	EFO_0004751
Disease	COVID-19, osteoarthritis	CCR9 LRRC2	7.55e-04	20	60	2	MONDO_0005178, MONDO_0100096
Disease	diet measurement, fasting blood insulin measurement	NRG3 AGBL1	9.15e-04	22	60	2	EFO_0004466, EFO_0008111
Disease	diet measurement, HOMA-IR	NRG3 AGBL1	1.00e-03	23	60	2	EFO_0004501, EFO_0008111
Disease	Attention deficit hyperactivity disorder	MED13 CHRNB2	1.09e-03	24	60	2	C1263846
Disease	traumatic brain injury (biomarker_via_orthology)	NOX1 PDE10A	1.09e-03	24	60	2	DOID:0081292 (biomarker_via_orthology)
Disease	Epileptic encephalopathy	GABBR2 SLC2A1	1.71e-03	30	60	2	C0543888

Protein segments in the cluster

Peptide	Gene	Start	Entry
IYISTLPYTQSVQIC	AKAP1	641	Q92667
YCLNTIIEAIEIPQF	EGFLAM	826	Q63HQ2
VISVVLQILRQCYPT	AGBL1	256	Q96MI9
VAICNPLLYTVAISQ	OR5D16	126	Q8NGK9
VTFASQVYREIICVP	ANK2	1311	Q01484
VYQRQVLSISCIIFG	NRG3	356	P56975
VGQYIFVNCPSISLL	NOX1	321	Q9Y5S8
NILVPSLTILCSYIF	OR8G1	206	Q15617
FSLPLLCIIVSYVQV	OR1A2	206	Q9Y585
NFSLLEICYVTIIIP	OR10AG1	56	Q8NH19
VCQPLLYVTILTQQA	OR9Q1	126	Q8NGQ5
VVNNLVAIPSYICYV	LPGAT1	26	Q92604
ILCSVPYATLVVYQT	GPR176	276	Q14439
EQLCGPYVFIIFTVL	SLC2A1	426	P11166
NYLNNPVFTVTIVCI	GPR50	181	Q13585
LPVVFQLACVDTYVL	OR4K2	181	Q8NGD2
NAVAIPCYTTLTQIL	PDE10A	721	Q9Y233
LNCEQPYVTTAIISI	KCND2	586	Q9NZV8
TLIQIIPTYIQLFQA	LRRC2	131	Q9BYS8
TASLLKQPIQYCVVI	NDNF	201	Q8TB73
QLQCVVIFVFQLTPV	ABCC2	541	Q92887
PLRTFVCQVTSVIFY	P2RY12	91	Q9H244
ICFAIINVVVFIQPY	LHFPL4	31	Q7Z7J7
ESCYTFVIIPQLLVH	OR10T2	71	Q8NGX3
LYRPILIIFTCTGIQ	GPRC6A	701	Q5T6X5
CTYVIEANPLSVVLL	CUBN	2946	O60494
VPLVTLLGCYVYEQV	FZD6	426	O60353
YIPVAIRTQILFFCV	DNAH1	3446	Q9P2D7
LYNNSVVCSFLPEVI	GDE1	196	Q9NZC3
IIQDYYCTLSPLQVQ	BTAF1	1516	O14981
FTIQTYIPCILTVVL	GABRG3	256	Q99928
TVFVLSQFPYNCILL	CCR9	261	P51686
SQFPYNCILLVQTID	CCR9	266	P51686
TIQTYIPCTLIVVLS	GABRG2	276	P18507
ICASFLTQSYQLPVL	FAM169A	166	Q9Y6X4
QPNVQFCIVALVIIF	GABBR2	716	O75899
VYLVPCSIFFILNSI	GPR139	191	Q6DWJ6
TILPLETLQFCVIFQ	CFAP74	971	Q9C0B2
RVIPVILQNCLSYSF	C18orf63	96	Q68DL7
LCYTTGIVPQLLVNL	OR2B8P	71	P59922
NITVPSCTILISYVF	OR8B2	206	Q96RD0
PFLCTIFSYLQIIVT	OR1L4	211	Q8NGR5
VQSVCFVVFLPVYLA	OR4B1	21	Q8NGF8
CIILVDTYSPSLVQL	PSAPL1	336	Q6NUJ1
NIITQYVCIRGVFIL	SLC35B4	246	Q969S0
NSFLYQCVPETVRIL	SLC29A2	86	Q14542
LLQPTVYLVTCANLT	NXPH1	11	P58417
LVTCVTFVATLPVLY	CCDC51	391	Q96ER9
LQLVVSVPYFVIFLT	SLC22A9	261	Q8IVM8
FDCLLTIVVNVSPYL	HID1	481	Q8IV36
PQQTTIVLVVCVLFL	SMIM17	91	P0DL12
IKSTVSVQIIPCQYL	MED13	1681	Q9UHV7
CIQLVAVPYIYSFLV	OR8U3	141	Q8NH85
FYTINLIIPCVLITS	CHRNB2	236	P17787
PGLYFIICQLQFLVQ	TNFSF8	136	P32971
YLTNNLLTDQCIPVL	PHLPP2	626	Q6ZVD8
LCASYVPVINQSVLV	SAGE2P	16	A6NJ88
QTVYAVPILIFSFVC	SLC38A2	291	Q96QD8
QFVLQFVVTLGICPY	TANGO6	146	Q9C0B7
FYCSIPRVQVAQILG	UBAC2	141	Q8NBM4
CLPLSIFIQIVQVSY	GTF3C1	911	Q12789
TPVIIAIQTFCYQKT	SLC35E3	111	Q7Z769
RILCLIPYNVINQSV	UNC79	606	Q9P2D8